Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma

Tracy L McGaha1, Constantin A Bona

  • 1Department of Microbiology, The Mount Sinai School of Medicine, Annenberg building 16-60, One Gustave L. Levy Place, New York, NY 10029, USA.

Autoimmunity Reviews
|July 10, 2003
PubMed

Insights

Interleukin-4 (IL-4) plays a key role in scleroderma development and embryonic viability. This study reveals IL-4

Area of Science:

  • Immunology
  • Developmental Biology
  • Genetics

Background:

  • Interleukin-4 (IL-4) is a cytokine implicated in profibrotic processes, including collagen gene upregulation.
  • Studies in TSK mice, a model for scleroderma, show that disrupting genes like STAT6, IL-4R, IL-4, or TGF-beta prevents skin sclerosis.
  • Homozygosity for the TSK mutation is lethal, causing embryonic death, but IL-4 gene disruption rescues TSK/TSK mice, indicating IL-4's role in embryonic development.

Purpose of the Study:

  • To investigate the role of IL-4 in the transcriptional regulation of the transforming growth factor-beta (TGF-beta) gene.
  • To understand the interplay between IL-4 and TGF-beta in the context of scleroderma and embryonic development.

Main Methods:

  • Gene expression analysis in TSK/+ and TSK/TSK IL-4-/- mice.
  • Investigating the IL-4 dependence of TGF-beta gene transcription.

Main Results:

  • The transcription of the TGF-beta gene is dependent on IL-4.
  • Expression of the TGF-beta gene is impaired in both TSK/+ and TSK/TSK IL-4-/- mice.
  • IL-4 deficiency rescues TSK/TSK mice from embryonic lethality.

Conclusions:

  • IL-4 is crucial for the normal expression of TGF-beta.
  • Impaired TGF-beta expression due to IL-4 deficiency contributes to the rescue of TSK/TSK mice from embryonic lethality.
  • These findings highlight a critical role for IL-4 in both fibrotic disease pathogenesis and embryonic development.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...